Meta-analysis: Thin struts equal better outcomes for drug-eluting stents

Sachin Kumar, MD, an interventional cardiologist at the University of Texas Health Science Center at Houston, cautioned that strut thickness “is just one side of the story.” Moderator of the session in which these data were presented, Dr. Kumar said that other factors Dr. Iantorno listed as potentially important, including polymer type and eluting drug, should not be discounted. However, he conceded that in the context of other recent evidence that strut thickness may be important to outcomes, particularly risk of stent thrombosis, this variable has become a focus of design improvements.

SOURCE: Iantorno M. Abstract CRT-100.87.